PM
RPTP

Parametrica Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Parametrica Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,511
Closed -$156K – 114
2014
Q2 		$156K Buy
+13,511
New +$123K 1.18% 50
2013
Q4 		– Sell
-16,355
Closed -$244K – 163
2013
Q3 		$244K Buy
+16,355
New +$196K 3.05% 11

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Parametrica Management's RPTP Position: Q3 2014 in Review

Parametrica Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2014, closing a stake of 13,511 shares — an estimated $156K sold.

Parametrica Management first reported a position in RPTP in Q3 2013 and held it in 2 quarters. The position peaked at $244K in Q3 2013. 82 funds tracked by Wall St. Rank hold RPTP as of Q3 2014.

  • Parametrica Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Parametrica Management sold 13,511 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2014, an estimated $156K.
  • Parametrica Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 2 quarters.
  • Parametrica Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $244K in Q3 2013.
  • 82 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2014.

Based on Parametrica Management's 13F filing for Q3 2014, filed 28 Oct 2014.